n.自血溶解（血）

Autohemolysis is a phenomenon where red blood cells break down and release their contents into the bloodstream without external injury.
In a patient with hemolytic anemia, autohemolysis can exacerbate the condition due to increased destruction of erythrocytes.
The presence of autoantibodies can lead to immune-mediated autohemolysis, causing chronic hemolysis.
After surgery, some patients may experience transient autohemolysis as a result of inflammation and tissue damage.
Pathological conditions like sickle cell disease can induce autohemolysis due to the abnormal shape and fragility of red blood cells.
Scientists studying blood compatibility often observe autohemolysis in mismatched blood samples.
Treatment for autoimmune hemolysis may involve managing the underlying cause to prevent continuous autohemolysis.
Hemoglobin released during autohemolysis can lead to elevated bilirubin levels, causing jaundice in severe cases.
Autohemolysis tests are used as a diagnostic tool in certain medical situations, particularly for diagnosing autoimmune disorders.
Monitoring for signs of autohemolysis, such as elevated creatinine kinase levels, is crucial in managing patients on immunosuppressive therapies.
自溶血是指红细胞在无外伤情况下自行分解并释放内容物到血液中的过程。
在溶血性贫血患者中，自溶血可能会加重病情，因为红细胞破坏增加。
自身抗体的存在可能导致免疫介导的自溶血，引起慢性溶血。
手术后，一些患者可能由于炎症和组织损伤而经历暂时性的自溶血。
病状如镰状细胞病会导致红细胞异常形状和脆性，从而诱发自溶血。
研究血液兼容性的科学家会观察到不匹配血液样本中的自溶血现象。
对抗自身免疫性溶血的治疗可能涉及管理潜在原因以防止持续的自溶血。
自溶血过程中释放的血红蛋白可能导致血清胆红素水平升高，严重时出现黄疸。
自溶血测试被用于某些医疗情况下的诊断，尤其对于识别自身免疫性疾病。
监测自溶血的迹象，如血清肌酸激酶水平升高，对管理接受免疫抑制疗法的患者至关重要。